Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CALADRIUS-BIOSCIENCES-INC-22412962/news/Caladrius-Biosciences-Licenses-Cell-Therapy-Technology-for-Ovarian-Cancer-and-Subleases-Irvine-Facil-22424300/?utm_source=whatsapp&utm_medium=social&utm_campaign=share